long intergenic non-protein coding RNA 1126Genealiases: []
Q-omics provides the consensus-scored LINC01126 profile across patient tissues and cancer cell-line models. LINC01126 expression is associated with patient survival in 26 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, LINC01126 is differentially expressed in 16, with the highest sampling consensus in KIRC. Additionally, LINC01126 RNA expression shows 20,400 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight ACC, KIRC, and THYM as cancer lineages where LINC01126 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01126 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01126 survival associations across molecular data types. LINC01126 RNA expression shows survival associations in the most cancer types (26). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01126 RNA expression–survival associations across cancer types. High LINC01126 expression shows unfavorable associations in ACC, UCEC and KIRC, but favorable associations in HNSC, BLCA and UCS. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for LINC01126 RNA expression.
This table summarizes LINC01126 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 16. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01126. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01126 shows lower tumor expression in THCA, KICH and BRCA and higher tumor expression in KIRC, LIHC and COAD. The KIRC box plot shows higher LINC01126 RNA expression in tumor versus normal tissue (log2 FC = +0.605, t-test p < 0.001).
This table shows molecular features associated with LINC01126 in patient tissues and cancer cell lines. In patient samples, LINC01126 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
